Skip to main content

Table 2 Weighted mean region-specific HBsAg prevalence in blood donors and hospital settings

From: Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

Study group      %HBsAg prevalence (range)   
Category no.studies N n Region* Weighted mean all data Weighted mean published data Pvalue References
Blood donors 13 658662 16788 A 2.53 (1.10, 8.70) 2.33 (1.70, 2.75) 0.51 [3440] (i-n)
  16 223949 6389 B 2.68 (1.70, 4.22) 3.44 (2.60, 4.20) 0.14 [4146] (o-x)
  4 149918 6675 C 4.25 (1.70, 4.90) 4.45 (2.92, 4.90) 0.50 [4749] (y)
Hospital† 5 37497 2977 A 3.40 (1.30, 13.80) 1.30 (0.90, 1.63) 0.40 [50] (z-cc)
  6 100343 7781 B 7.15 (2.90, 13.60) 5.73 (2.90, 13.60) 1.00 [51, 52] (dd-gg)
  2 28392 6037 C - 10.88 (9.60, 21.30) - [53, 54]
  1. Abbreviations: N number of subjects, n number of cases
  2. P value calculated by the two-sided Mann-Whitney test (difference in prevalence of all data and only published data)
  3. * Region A: Marmara and Aegean, B: Black Sea, Central Anatolia and Mediterranean, C: Eastern and South-eastern
  4. † Studies based in hospital settings on non-liver-related conditions